Your new experience awaits. Try the new design now and help us make it even better

CASE REPORT article

Front. Genet.

Sec. Genetics of Common and Rare Diseases

Volume 16 - 2025 | doi: 10.3389/fgene.2025.1626155

Identification and functional characterization of a novel heterozygous splice-donor (c.647+1G>A) site mutation in SPTB gene causes hereditary spherocytosis with hemolytic anemia

Provisionally accepted
KE  CAOKE CAO1Xiaojuan  LuoXiaojuan Luo1Lianlian  LiuLianlian Liu1Xiaoning  MaoXiaoning Mao1Ruping  LiuRuping Liu2Yunsheng  ChenYunsheng Chen1Prof. (Dr.) Santasree  BanerjeeProf. (Dr.) Santasree Banerjee2*
  • 1Shenzhen Children's Hospital, Shenzhen, China
  • 2Jilin University, Changchun, China

The final, formatted version of the article will be published soon.

Objective: Hereditary spherocytosis (HS) is an inherited disorder characterized by spherical-shaped erythrocytes and abnormalities of several erythrocyte membrane proteins with extreme genotypic and phenotypic heterogeneity. HS patients were clinically diagnosed by the presence of spherical-shaped erythrocytes on the peripheral blood smear, haemolytic anaemia, jaundice, splenomegaly, with or without cholelithiasis or gallstones. Till date, mutations of five genes (ANK1, EPB42, SLC4A1, SPTA1, and SPTB) have been reported to be associated with different subtypes of HS. Germline mutations of SPTB gene causes autosomal dominant HS (Spherocytosis 2, SPH2), the rarest subtypes of HS. Methods: In this study, we investigated a 10-year-old Chinese girl clinically diagnosed with HS and neonatal hemolytic anemia. Proband's mother was also identified with HS and hemolytic anemia but proband's father was phenotypically normal. We performed standard G-banding karyotype to identify structural abnormalities of chromosomes in this proband. Then, we performed whole exome sequencing and Sanger sequencing to identify the disease-causing variants in this proband. Finally, we functionally characterize the identified novel variant by performing reverse transcription polymerase chain reaction, cDNA sequencing, quantitative real time PCR and western blot. Results: Whole exome sequencing identified a heterozygous novel splice-donor-site (c.647+1G>A) mutation in SPTB gene in the proband. Sanger sequencing confirmed that the proband was inherited this mutation from her mother, while her father was devoid of it. Reverse transcription polymerase chain reaction and cDNA sequencing showed that this novel splice-donor-site (c.647+1G>A) mutation causes abolition of wild type splice donor site which leads to the aberrant splicing of SPTB mRNA followed by the formation of alternative transcript with complete loss of exon 5. Relative expression of mutated SPTB mRNA was significantly reduced in the proband and her mother compared with her father showing normal expression of wild type SPTB mRNA. Conclusion: Our present study highlighted the significance of whole exome sequencing as the most potential way for genetic molecular diagnosis for the patients with HS.

Keywords: Hereditary spherocytosis, Novel mutation, SPTB gene, hemolytic anemia, splice-donor site mutation

Received: 10 May 2025; Accepted: 10 Oct 2025.

Copyright: © 2025 CAO, Luo, Liu, Mao, Liu, Chen and Banerjee. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Prof. (Dr.) Santasree Banerjee, santasree.banerjee@yahoo.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.